"Ghoulish" Michael Jackson Biopic Branded "One of the Worst Films of 2026" In First Reviews

Why It Matters

The movie’s commercial potential highlights the power of legacy branding, while its critical failure raises questions about the viability of sanitized celebrity biopics. Studios will watch the box‑office results to gauge audience appetite for music‑driven narratives versus substantive storytelling.

Key Takeaways

• Michael holds 35% Rotten Tomatoes rating on opening week.
• Box office tracking suggests record for musical biopics in US.
• Critics call film bland, lacking depth on Jackson's controversial side.
• Family‑produced biopic stars nephew Jaafar Jackson as lead.
• Release date set for April 22, 2026.

Pulse Analysis

The upcoming *Michael* biopic arrives at a moment when music‑driven films dominate the summer slate, yet its reception underscores a growing divide between fan‑driven hype and critical standards. While the film is poised to break box‑office records for the genre, its 35% Rotten Tomatoes rating signals that audiences may be less forgiving of narratives that sidestep the complexities of iconic figures. Industry analysts note that the involvement of Jackson’s relatives and the casting of his nephew provide a veneer of authenticity, but critics argue this closeness results in a sanitized, promotional piece rather than a nuanced portrait.

Critics from the BBC to The Independent have uniformly described *Michael* as a glossy tribute lacking the depth required for a compelling biopic. The film’s focus on high‑energy musical numbers and iconic choreography, while entertaining, fails to address the darker chapters of Jackson’s life, a gap that reviewers say diminishes its artistic credibility. This pattern mirrors recent trends where studios prioritize spectacle over substance, betting on name recognition to drive ticket sales. The backlash may prompt future biopics to balance reverence with investigative storytelling, especially as streaming platforms demand richer, more authentic content.

For investors and studios, the film’s performance will serve as a litmus test for the commercial viability of legacy‑driven projects that prioritize fan service. Should *Michael* achieve strong box‑office returns despite critical disdain, it could reinforce a model where brand power outweighs narrative depth. Conversely, a muted financial response would signal that audiences increasingly expect comprehensive storytelling, even from beloved icons. Either outcome will shape how Hollywood approaches celebrity biopics in the coming years, influencing budget allocations, talent partnerships, and marketing strategies.